Xue-Kun Wang, Xinyu Zhang, Jin Xu, Shuhai Xu, Keyuan Huang, Qiaoling Ni, Xin-Yi Shen, Wei-Tao Zhang, Tao Liu, Taimin Dong, Dan Mao, Chunguang Zheng, Wei Yu, Qingcheng Guo, Zhixin Li, Jiawei Cao, Fubo Han, Lu-Sha Ji, Wei-Zhu Qian, Sheng Hou, Jun Li, Ziqiao Sun, Jianxin Dai, Yajun Guo, Da-peng Zhang, Huai-Zu Guo (2025). High-concentration L-methionine as a potent antioxidant for oxidation resistance and stability enhancement in high-concentration antibody therapeutics. International Journal of Pharmaceutics: X.DOI
Yan Jiang, Bing-Wu Wang, Qun Cheng, Y. Huo, Mao-Zhong Hu, Qin Wang, Li Mao, Hanqing Cai, Li-Ge Song, Ji Hu, Xiaojiang Xiong, Dongfang Liu, Zhifeng Sheng, AiGe Yang, Shigui Yan, Jun Zhang, Sheng Hou, Yajun Guo, Wei-Bo Xia (2025). Efficacy and safety of denosumab biosimilar CMAB807 versus Prolia® in Chinese postmenopausal women with osteoporosis. Endocrine.DOI
Meng-Jiao Xu, Ming-Ming Xu, Tao Liu, Dan Mao, Chunguang Zheng, Wei Yu, Qingcheng Guo, Zhi-Xin Li, Tian-Yu Gao, Yule Ren, Weifan Zhu, Huangzhen Zhuang, Zhiyuan Pan, Fugui Wang, X. Fang, Shan-Shan Dong, Lan-Kun Song, Xi Chen, Aiying Nie, Lu-Sha Ji, Wei-Zhu Qian, Sheng Hou, Jun Li, Yajun Guo, Da-peng Zhang, Jin Xu, Hong Shao, Huai-Zu Guo (2025). Feasibility of Rapid Regulatory Differentiation of TNF Receptor 2-Fc Fusion Protein Products from Various Manufacturers in the Chinese Market Using a Novel Mass Spectrometry-Based Multi-attribute Method (MAM). Journal of the American Society for Mass Spectrometry.DOI
K. Lai, Zhijun Yan, Dong-Hua Qian, Xiaoju Zhang, T. Bian, Xiaotian Dai, Hui-Ping Li, Lin Lin, Jin Wang, Linwei Wang, Jing-Ping Yang, Yao-Min Hu, Hui Li, Xiuhong Nie, Fa-Guang Jin, Guoxiang Li, Shenghua Sun, Feng Xu, Hui Zhao, Yu-Sheng Chen, Chuntao Liu, Huili Zhu, Jing Li, Yajun Guo, Nan-Shan Zhong (2025). Benefits of CMAB007 in Chinese Patients Having Inadequately Controlled Moderate/Severe Asthma With Increased Total IgE: A Randomized Phase 3 Trial. Allergy Asthma and Immunology Research.DOI
Qing An, Yingxin Zheng, Yirong Zhao, Tao Liu, Huai-Zu Guo, Da-peng Zhang, Wei-Zhu Qian, Hao Wang, Yajun Guo, S. Hou, Jing Li (2019). Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system. Drug Design, Development and Therapy.DOI
Bo-hua Li, Lei Zhao, Huai-Zu Guo, Chong Wang, Xunming Zhang, Lan Wu, Lin Chen, Qing Tong, Wei-Zhu Qian, Hao Wang, Yajun Guo (2017). Running head: ANTITUMOR ACTIVITY OF NEW RITUXIMAB VARIANTS.
Yuan-Kai Shi, Jin Li, Jian-Ming Xu, Ying Cheng, Wei Liu, Ying Cheng, L. Bai, Yiping Zhang, Xiaohui He, Yi Luo, Yun-Peng Liu, Q. Yao, Yu-Hong Li, S. Qin, Xiao-Hua Hu, Yajun Guo, Yan Sun (2017). A phase III trial (ZJBIO009): CMAB009 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients.DOI
Xin Shi, Yong-Qiang Deng, Hua-Jing Wang, G. Ji, Wen-Long Tan, Tao Jiang, Xiaofeng Li, Hui Zhao, Tian Xia, Yanchun Meng, Chao Wang, Xiao-Jie Yu, Yang Yang, Bohua Li, E. Qin, Jianxin Dai, Cheng-Feng Qin, Yajun Guo (2016). A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion. mAbs.DOI
H. Mao, Fei Pan, Hongxia Guo, F. Bu, Tong Xin, Shukun Chen, Yajun Guo (2016). Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients. Tumor Biology.DOI
Junjie Zhang, T. Qin, Lu Xu, Bo-Ning Liu, Yantao Li, Huai-Zu Guo, Lan-Kun Song, Qingcheng Guo, Jin Xu, Da-peng Zhang, Wei-Zhu Qian, Jianxin Dai, Hao Wang, S. Hou, Yajun Guo (2016). Development and Validation of a Peptide Mapping Method for the Characterization of Adalimumab with QDa Detector. Chromatographia.DOI
Bo-Ning Liu, Huai-Zu Guo, Junjie Zhang, Jingya Xue, Yun Yang, T. Qin, Jin Xu, Qingcheng Guo, Da-peng Zhang, Wei-Zhu Qian, Bo-hua Li, S. Hou, Jianxin Dai, Yajun Guo, Hao Wang (2016). In-Depth Characterization of a Pro-Antibody-Drug Conjugate by LC-MS. Molecular Pharmaceutics.DOI
Yang Pu, M. Xu, Yong Liang, Kai-Ting Yang, Yajun Guo, Xuanming Yang, Yang-Xin Fu (2016). Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse. Science Translational Medicine.DOI
Lu Xu, Xin Tong, Su-jie Zhang, F. Yin, Xiaoyan Li, Huafeng Wei, Cheng Li, Yajun Guo, Jian Zhao (2016). ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma. Tumor Biology.DOI
Fei Pan, H. Mao, F. Bu, Xin Tong, Jingjing Li, Su-jie Zhang, Xing Liu, Ling-Xiong Wang, Liang-Liang Wu, Rui Chen, Huafeng Wei, Bohua Li, Cheng Li, Yun-Sheng Yang, C. Steer, Jian Zhao, Yajun Guo (2016). Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma. OncoTarget.DOI
Xi Chen, Jin Xu, Qingcheng Guo, Lingfei Wang, Yun Yang, Huai-Zu Guo, Nana Gu, Da-peng Zhang, Wei-Zhu Qian, S. Hou, Jing Li, Jianxin Dai, Yajun Guo, Hao Wang (2016). Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancer. Biochemical and Biophysical Research Communications - BBRC.DOI
Y. Jing, Cunchao Zhang, Tuo Fu, Cheng Jiang, Kai Ma, Da-peng Zhang, S. Hou, Jianxin Dai, Hao Wang, Xue-Guang Zhang, Geng Kou, Yajun Guo (2016). Combination of dextran sulfate and recombinant trypsin on aggregation of Chinese hamster ovary cells. Cytotechnology (Dordrecht).DOI
Jie Gao, Wei Li, Yajun Guo, Si-Shen Feng (2016). Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells. Nanomedicine.DOI
Tao Liu, Huai-Zu Guo, Lei Zhu, Yingxin Zheng, Jin Xu, Qingcheng Guo, Da-peng Zhang, Wei-Zhu Qian, Jianxin Dai, Yajun Guo, S. Hou, Hao Wang (2016). Fast Characterization of Fc-Containing Proteins by Middle-Down Mass Spectrometry Following IdeS Digestion. Chromatographia.DOI
Yun Yang, Qingcheng Guo, X. Chen, Junjie Zhang, Huai-Zu Guo, Wei-Zhu Qian, S. Hou, Jianxin Dai, Bo-hua Li, Yajun Guo, Hao Wang (2016). Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy. mAbs.DOI
Yantao Li, Tuo Fu, Tao Liu, Huai-Zu Guo, Qingcheng Guo, Jin Xu, Da-peng Zhang, Wei-Zhu Qian, Jianxin Dai, Bo-hua Li, Yajun Guo, S. Hou, Hao Wang (2016). Characterization of alanine to valine sequence variants in the Fc region of nivolumab biosimilar produced in Chinese hamster ovary cells. mAbs.DOI
Bo-Ning Liu, Huai-Zu Guo, Jin Xu, T. Qin, Lu Xu, Junjie Zhang, Qingcheng Guo, Da-peng Zhang, Wei-Zhu Qian, Bo-hua Li, Jianxin Dai, S. Hou, Yajun Guo, Hao Wang (2016). Acid-induced aggregation propensity of nivolumab is dependent on the Fc. mAbs.DOI
Lei Cao, Xiao-yu Fan, W. Jing, Yingchao Liang, Rui Chen, Yingying Liu, Minhui Zhu, Rongjie Jia, Hao Wang, Xue-Guang Zhang, Yan-Yun Zhang, Xuyu Zhou, Jian Zhao, Yajun Guo (2015). Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin–NF-κB–HIF-1α pathway. OncoTarget.DOI
Yun Yang, Qingcheng Guo, Mao Xia, Yantao Li, Xiaoyun Peng, Tao Liu, Xin Tong, Jin Xu, Huai-Zu Guo, Wei-Zhu Qian, S. Hou, Jianxin Dai, Hao Wang, Rong-huo Liu, Yajun Guo (2015). Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency. mAbs.DOI
Wen-Yan Fu, Xiaoze Wang, Wei-Li Yang, Hiroaki Takeda, Shi Hu, Z. Lou, Jian Zhao, Augus N. Bethune, Yajun Guo (2015). RETRACTED ARTICLE: Structure-based development and optimization of therapy antibody drugs against TNFα. Amino Acids.DOI
Hua-Fei Li, Zheng Xu, Cong Wu, He Zhao, Ge Zhang, Hua-Jing Wang, Chang-Hong Ke, Bohua Li, Yajun Guo (2015). WITHDRAWN: Effective suppression of Rituximab-resistant B-cell lymphoma by a comb-like anti-CD20 mAb nanocluster. Cancer Letters.DOI
Wen-Yan Fu, Xiaoze Wang, Wei-Li Yang, Hiroaki Takeda, Shi Hu, Z. Lou, Jian Zhao, Augus N. Bethune, Yajun Guo (2015). Retraction Note to: Structure-based development and optimization of therapy antibody drugs against TNFα. Amino Acids.DOI
Chang-Hong Ke, Jia-Nan Chen, Yajun Guo, Zheng W. Chen, Ji-Ye Cai (2015). Migration mechanism of mesenchymal stem cells studied by QD/NSOM. Biochimica et Biophysica Acta.DOI
Xiao-yu Fan, Chun-yan He, W. Jing, Xuyu Zhou, Rui Chen, Lei Cao, Minhui Zhu, Rongjie Jia, Hao Wang, Yajun Guo, Jian Zhao (2015). Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis. Cancer Research.DOI
Xiao-Bin Gu, T. Tian, Bo Zhang, Yang Liu, Chaoqun Yuan, Lijuan Shao, Yajun Guo, K. Fan (2015). Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer. Tumor Biology.DOI
Ya-Lin Chen, Lin Chen, Qiong Lu, Yanchun Meng, Chao Wang, Lin-Fei Wang, Hua-Jing Wang, Xiao-Jie Yu, Yajun Zhang, Lei Zhao, Bo-hua Li, Yajun Guo (2015). Optimization of anti-CD20 humanized antibody hu8E4 by site-directed mutation based on epitope analysis. Biochemical and Biophysical Research Communications - BBRC.DOI
G. Ji, Yong-Qiang Deng, Xiao-Jie Yu, Tao Jiang, Hua-Jing Wang, Xin Shi, Da-peng Zhang, Xiao-Feng Li, Shun-Ya Zhu, Hui Zhao, Jian-Xin Dai, Cheng-Feng Qin, Yajun Guo (2015). Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III. PLoS ONE.DOI
T. Tian, Xiao-Bin Gu, Bo Zhang, Yang Liu, Chaoqun Yuan, Lijuan Shao, Yajun Guo, K. Fan (2015). Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer. Cancer Biomarkers.DOI
Shi Hu, Yuna Sun, Yanchun Meng, Xiaoze Wang, Wei-Li Yang, Wen-Yan Fu, Huai-Zu Guo, Wei-Zhu Qian, S. Hou, Bo-hua Li, Z. Rao, Z. Lou, Yajun Guo (2015). Molecular architecture of the ErbB2 extracellular domain homodimer. OncoTarget.DOI
Xiaoyun Peng, Bo-Ning Liu, Yantao Li, Hui Wang, X. Chen, Huai-Zu Guo, Qingcheng Guo, Jin Xu, Hao Wang, Da-peng Zhang, Jianxin Dai, S. Hou, Yajun Guo (2015). Development and Validation of LC–MS/MS Method for the Quantitation of Infliximab in Human Serum. Chromatographia.DOI
Hao Song, Xiao Su, Kai-Xuan Yang, Fang-Fang Niu, Jun Li, Jinjing Song, Huaiwen Chen, Bo-hua Li, Wei Li, Wei-Zhu Qian, Xue-Song Cao, Shangjing Guo, Jianxin Dai, Si-Shen Feng, Yajun Guo, Chuan Yin, Jie Gao (2015). CD20 Antibody-Conjugated Immunoliposomes for Targeted Chemotherapy of Melanoma Cancer Initiating Cells. Journal of Biomedical Nanotechnology.DOI
Yajun Guo (2015). [Progress in monoclonal antibody-based immunotherapy for cancer treatment]. Sheng wu gong cheng xue bao = Chinese journal of biotechnology.
Yingying Liu, Lei Cao, Rui Chen, Xuyu Zhou, Xiao-yu Fan, Yingchao Liang, Rongjie Jia, Hao Wang, Guoke Liu, Yajun Guo, Jian Zhao (2015). Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of β‐Catenin in Mice. Stem Cells.DOI
F. Bu, Xing Liu, Jingjing Li, Shukun Chen, Xin Tong, Chun-Sheng Ma, H. Mao, Fei Pan, Xiao-Yan Li, Bo Chen, Li-Yan Xu, En-Min Li, Geng Kou, Jun Han, Shangjing Guo, Jian Zhao, Yajun Guo (2014). TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma. OncoTarget.DOI
Xin Tong, Lili Li, Xiao-Yan Li, Lei Heng, Lan Zhong, X. Su, Rong Rong, Shi Hu, Wen-Jia Liu, B. Jia, Xing Liu, Geng Kou, Jun Han, Shangjing Guo, Yi Hu, Cheng Li, Q. Tao, Yajun Guo (2014). SOX10, a novel HMG-box-containing tumor suppressor, inhibits growth and metastasis of digestive cancers by suppressing the Wnt/β-catenin pathway. OncoTarget.DOI
Jie Gao, Yunlei Xia, Huaiwen Chen, Yongsheng Yu, Jinjing Song, Wei Li, Wei-Zhu Qian, Hao Wang, Jianxin Dai, Yajun Guo (2014). Polymer-lipid hybrid nanoparticles conjugated with anti-EGF receptor antibody for targeted drug delivery to hepatocellular carcinoma. Nanomedicine.DOI
Wei Li, Huafeng Wei, Hua-Fei Li, Jie Gao, Si-Shen Feng, Yajun Guo (2014). Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology. Nanomedicine.DOI
Lei Zhao, Feiyue Xie, Xin Tong, Hua-Fei Li, Ya-Lin Chen, Wei-Zhu Qian, Shuyan Duan, Jui-Pin Zheng, Zi-Ye Zhao, Bo-hua Li, Da-peng Zhang, Jian Zhao, Jianxin Dai, Hao Wang, S. Hou, Yajun Guo (2014). Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20–243 CrossMab. mAbs.DOI
Qing Tong, Shan He, Fangyu Xie, Kazuhiro Mochizuki, Yongnian Liu, I. Mochizuki, Lijun Meng, Hongxing Sun, Yan-Yun Zhang, Yajun Guo, E. Hexner, Yi Zhang (2014). Aplastic Anemia in Mice Promotes Th 1 Cell Responses Mediating Posttranslational Expression of T-bet and Ezh 2 Regulates Transcriptional and.
Minhui Zhu, F. Yin, Li-Xue Yang, S. Chen, Rui Chen, Xuyu Zhou, Wei Jing, Xiao-yu Fan, Rongjie Jia, Hua-Jing Wang, H. Zheng, Jian Zhao, Yajun Guo (2014). Contribution of TIP30 to chemoresistance in laryngeal carcinoma. Cell Death and Disease.DOI
Bo Zhang, Jianxin Dai, Hua-Qing Wang, Huafeng Wei, Jian Zhao, Yajun Guo, K. Fan (2014). Anti-osteopontin monoclonal antibody prevents ovariectomy-induced osteoporosis in mice by promotion of osteoclast apoptosis. Biochemical and Biophysical Research Communications - BBRC.DOI
Si-Qi Han, Yanchun Meng, Qing Tong, Guang-Chao Li, Xunming Zhang, Ya-Lin Chen, Shi Hu, Lei Zheng, Wenlong Tan, Hui Li, Yang Chen, Ge Zhang, Bohua Li, Yajun Guo (2014). The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancer. mAbs.DOI
Jie Gao, Si-Shen Feng, Yajun Guo (2014). Nanomedicine for treatment of cancer stem cells. Nanomedicine.DOI
Mei-Jin Huang, Ziyuan Xia, Yang Wang, Liang Huang, Qianyun Ma, Xia Chen, Hao Wang, B. Lu, Yajun Guo (2014). Generation of a monoclonal antibody specific to a new candidate tumor suppressor, cell adhesion molecule 2. Tumor Biology.DOI
Xuanming Yang, Xunming Zhang, M. Fu, R. Weichselbaum, T. Gajewski, Yajun Guo, Yang-Xin Fu (2014). Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses. Cancer Cell.DOI
Minhui Zhu, F. Yin, Xiao-yu Fan, W. Jing, R. Chen, Lian-jie Liu, L. Zhang, Yan Liu, Yingchao Liang, F. Bu, X. Tong, H. Zheng, Jian Zhao, Yajun Guo (2014). Decreased TIP30 promotes Snail-mediated epithelial–mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma. Oncogene.DOI
Guang-Chao Li, Likun Zhao, Wei Li, K. Fan, Wei-Zhu Qian, S. Hou, Hao Wang, Jianxin Dai, Huafeng Wei, Yajun Guo (2014). Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression. OncoTarget.DOI
Tian Xia, Shuaiyi Liang, Hua-Jing Wang, Shi Hu, Yuna Sun, Xiao-Jie Yu, Jun Han, Jun Li, Shangjing Guo, Jianxin Dai, Z. Lou, Yajun Guo (2014). Structural basis for the neutralization and specificity of Staphylococcal enterotoxin B against its MHC Class II binding site. mAbs.DOI
Jin Xu, Shi Hu, Xiaoze Wang, Zi-Ye Zhao, Xinyue Zhang, Hao Wang, Da-peng Zhang, Yajun Guo (2014). Structure basis for the unique specificity of medaka enteropeptidase light chain. Protein & Cell.DOI
Ang Huang, Bo Zhang, Wei-Wei Yan, Bo Wang, Huafeng Wei, Fan Zhang, Lang Wu, K. Fan, Yajun Guo (2014). Myeloid-Derived Suppressor Cells Regulate Immune Response in Patients with Chronic Hepatitis B Virus Infection through PD-1–Induced IL-10. Journal of Immunology.DOI
Huafeng Wei, Likun Zhao, I. Hellstrom, K. Hellstrom, Yajun Guo (2014). Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapy. Oncoimmunology.DOI
Shi Hu, Shuaiyi Liang, Huai-Zu Guo, Da-peng Zhang, Hui Li, Xiaoze Wang, Wei-Li Yang, Wei-Zhu Qian, S. Hou, Hao Wang, Yajun Guo, Z. Lou (2014). Comparison of the inhibition mechanisms of Adalimumab and Infliximab in treating tumor necrosis factor α-associated diseases from a molecular view. Journal of Biological Chemistry.DOI
Qing Tong, Shan He, Fangyu Xie, Kazuhiro Mochizuki, Yongnian Liu, I. Mochizuki, Lijun Meng, Hongxing Sun, Yan-Yun Zhang, Yajun Guo, E. Hexner, Yi Zhang (2014). Ezh2 regulates transcriptional and post-translational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice. Journal of Immunology.DOI
Lei Zhu, Qingcheng Guo, Huai-Zu Guo, Tao Liu, Yingxin Zheng, Peiming Gu, Xi Chen, Hao Wang, S. Hou, Yajun Guo (2014). Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry. mAbs.DOI
Shiwei Guo, W. Jing, Xian-gui Hu, Xuyu Zhou, L. Liu, Minhui Zhu, F. Yin, R. Chen, Jian Zhao, Yajun Guo (2014). Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients. International Journal of Cancer.DOI
Yi-Hua Wang, F. Bu, C. Royer, S. Serres, J. Larkin, M. S. Soto, N. Sibson, Victoria Salter, F. Fritzsche, Casmir Turnquist, S. Koch, J. Zak, S. Zhong, Guo-Bin Wu, Anmin Liang, P. Olofsen, H. Moch, D. Hancock, J. Downward, R. Goldin, Jian Zhao, Xin Tong, Yajun Guo, Xin Lu (2014). ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1. Nature Cell Biology.DOI
Wei Li, Mengxin Zhao, Chang-Hong Ke, Ge Zhang, Li Zhang, Hua-Fei Li, Fulei Zhang, Yun Sun, Jianxin Dai, Hao Wang, Yajun Guo (2013). Nano Polymeric Carrier Fabrication Technologies for Advanced Antitumor Therapy. BioMed Research International.DOI
Kazuhiro Mochizuki, Fangyu Xie, Shan He, Qing Tong, Yongnian Liu, I. Mochizuki, Yajun Guo, Koji Kato, H. Yagita, S. Mineishi, Yi Zhang (2013). Delta-like Ligand 4 Identifies a Previously Uncharacterized Population of Inflammatory Dendritic Cells That Plays Important Roles in Eliciting Allogeneic T-cell Responses in Mice. Journal of Immunology.DOI
Bo-hua Li, Yanchun Meng, Lei Zheng, Xunming Zhang, Qing Tong, Wenlong Tan, Shi Hu, Hui Li, Yang Chen, Jinjing Song, Ge Zhang, Lei Zhao, Da-peng Zhang, S. Hou, Wei-Zhu Qian, Yajun Guo (2013). Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerization. Cancer Research.DOI
Ang Huang, Bo Zhang, Bo Wang, Fan Zhang, Ke-Xing Fan, Yajun Guo (2013). Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. Cancer Immunology and Immunotherapy.DOI
Jie Gao, Huaiwen Chen, Hao Song, Xiao Su, Fang-Fang Niu, Wei Li, Bo-hua Li, Jianxin Dai, Hao Wang, Yajun Guo (2013). Antibody-targeted immunoliposomes for cancer treatment. Mini-Reviews in Medical Chemistry.DOI
Lei Zhao, Qing Tong, Wei-Zhu Qian, Bo-hua Li, Da-peng Zhang, Tuo Fu, Shuyan Duan, Xue-Guang Zhang, Jian Zhao, Jianxin Dai, Hao Wang, S. Hou, Yajun Guo (2013). Eradication of non-Hodgkin lymphoma through the induction of tumor-specific T-cell immunity by CD20-Flex BiFP. Blood.DOI
Shuaiyi Liang, Jianxin Dai, S. Hou, Lishu Su, Da-peng Zhang, Huai-Zu Guo, Shi Hu, Hao Wang, Z. Rao, Yajun Guo, Z. Lou (2013). Structural Basis for Treating Tumor Necrosis Factor α (TNFα)-associated Diseases with the Therapeutic Antibody Infliximab*. Journal of Biological Chemistry.DOI
Bei-Bei Liang, Yajun Guo, Jian Zhao (2013). ASPP2 gene silence promotes hepatocellular carcinoma cell proliferation via regulating autophagy under starvation: ASPP2 gene silence promotes hepatocellular carcinoma cell proliferation via regulating autophagy under starvation.DOI
Wei Li, Si-Shen Feng, Yajun Guo (2013). Polymeric nanoparticulates for cancer immunotherapy. Nanomedicine.DOI
Jie Gao, Huaiwen Chen, Yongsheng Yu, Jinjing Song, Hao Song, Xiao Su, Wei Li, Xin Tong, Wei-Zhu Qian, Hao Wang, Jianxin Dai, Yajun Guo (2013). Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA. Biomaterials.DOI
Shi Hu, Shuaiyi Liang, Huai-Zu Guo, Da-peng Zhang, Hao Li, Xiaoze Wang, Wei-Li Yang, Wei-Zhu Qian, S. Hou, Hua-Jing Wang, Yajun Guo, Z. Lou (2013). Comparison of the inhibition mechanisms of adalimumab and infliximab in treating tumor necrosis factor alpha-associated diseases from a molecular view.DOI
Bei-Bei Liang, R. Chen, Tao Wang, Lei Cao, Yingying Liu, F. Yin, Minhui Zhu, Xiao-yu Fan, Yingchao Liang, Lu Zhang, Yajun Guo, Jian Zhao (2013). Myeloid Differentiation Factor 88 Promotes Growth and Metastasis of Human Hepatocellular Carcinoma. Clinical Cancer Research.DOI
Yuwei Zhu, Jianxin Dai, Tian-Cheng Zhang, Xu Li, P. Fang, Hua-Jing Wang, Yongliang Jiang, Xiao-Jie Yu, Tian Xia, L. Niu, Yajun Guo, M. Teng (2013). Structural Insights into the Neutralization Mechanism of Monoclonal Antibody 6C2 against Ricin*. Journal of Biological Chemistry.DOI
Lili Li, J. Ying, Xin Tong, Lan Zhong, X. Su, T. Xiang, Xingsheng Shu, Rong Rong, L. Xiong, Hong-Yu Li, A. Chan, R. Ambinder, Yajun Guo, Q. Tao (2013). Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas. Cellular and Molecular Life Sciences.DOI
Song-Wei Tan, Xu Li, Yajun Guo, Zhiping Zhang (2013). Lipid-enveloped hybrid nanoparticles for drug delivery. Nanoscale.DOI
Wei Li, Li Zhang, Ge Zhang, Huafeng Wei, Mengxin Zhao, Hua-Fei Li, Shangjing Guo, Jie Gao, Geng Kou, Bo-hua Li, Jianxin Dai, Hao Wang, Yajun Guo (2013). The finely regulating well-defined functional polymeric nanocarriers for anti-tumor immunotherapy. Mini-Reviews in Medical Chemistry.DOI
Huafeng Wei, Likun Zhao, Wei Li, K. Fan, Wei-Zhu Qian, S. Hou, Hao Wang, M. Dai, I. Hellstrom, K. Hellstrom, Yajun Guo (2013). Combinatorial PD-1 Blockade and CD137 Activation Has Therapeutic Efficacy in Murine Cancer Models and Synergizes with Cisplatin. PLoS ONE.DOI
Wenlong Tan, Yanchun Meng, Hui Li, Yang Chen, Si-Qi Han, Jing Zeng, Ang Huang, Bohua Li, Yan-Yun Zhang, Yajun Guo (2013). A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity. mAbs.DOI
Bo Zhou, Bi-rong Lin, Jing Li, Wei-Zhu Qian, S. Hou, Da-peng Zhang, Geng Kou, Bo-hua Li, Hao Wang, Yong-chuan Chen, Yajun Guo (2012). Tolerability, pharmacokinetics and pharmacodynamics of CMAB007, a humanized anti-immunoglobulin E monoclonal antibody, in healthy Chinese subjects. mAbs.DOI
Yajun Guo, S. Hou, Huai-Zu Guo, Da-peng Zhang, Min Tan (2012). Achromobacter protease I variant.
Jie Gao, Si-Shen Feng, Yajun Guo (2012). Nanomedicine against multidrug resistance in cancer treatment. Nanomedicine.DOI
Wei Li, Hua-Fei Li, Jinfeng Li, Hua-Jing Wang, He Zhao, Li Zhang, Yunlei Xia, Zengwei Ye, Jie Gao, Jianxin Dai, Hao Wang, Yajun Guo (2012). Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors. International Journal of Nanomedicine.DOI
Chun-yan He, Xiao-yu Fan, R. Chen, Bei-Bei Liang, Lei Cao, Yajun Guo, Jian Zhao (2012). Osteopontin is involved in estrogen-mediated protection against diethylnitrosamine-induced liver injury in mice. Food and Chemical Toxicology.DOI
Chang-Chun Chen, Shuhui Wang, Hua-Jing Wang, Xiao-Yan Mao, Tian-Cheng Zhang, G. Ji, Xin Shi, Tian Xia, Wei-Jia Lu, Da-peng Zhang, Jianxin Dai, Yajun Guo (2012). Potent Neutralization of Botulinum Neurotoxin/B by Synergistic Action of Antibodies Recognizing Protein and Ganglioside Receptor Binding Domain. PLoS ONE.DOI
Zhiping Zhang, Yajun Guo, Si-Shen Feng (2012). Nanoimmunotherapy: application of nanotechnology for sustained and targeted delivery of antigens to dendritic cells. Nanomedicine.DOI
Wei Li, Si-Shen Feng, Yajun Guo (2012). Tailoring polymeric micelles to optimize delivery to solid tumors. Nanomedicine.DOI
Yu Mi, Yajun Guo, Si-Shen Feng (2012). Nanomedicine for multimodality treatment of cancer. Nanomedicine.DOI
Xian-ping Li, Jing Li, Heng Yan, Bo Zhou, Bo-hua Li, Wei-Zhu Qian, S. Hou, Hao Wang, F. Hao, Yajun Guo (2012). Tolerability, pharmacokinetics and pharmacodynamics of CMAB001, an anti-CD11a antibody, in Chinese healthy volunteers and psoriatic patients. Acta Pharmacologica Sinica.DOI
Kazuhiro Mochizuki, Fangyu Xie, Shan He, Qing Tong, Yongnian Liu, Yajun Guo, Koji Kato, H. Yagita, S. Mineishi, Yi Zhang (2012). Identification of Previously Uncharacterized Delta 4-Positive Inflammatory Plasmacytoid Dendritic Cells That Play Important Roles in Eliciting Graft-Versus-Host Disease in Mice.DOI
Shuhui Wang, Chang-Chun Chen, Yanchun Meng, Shi Hu, Lei Zheng, Jinjing Song, Da-peng Zhang, Bo-hua Li, Yajun Guo (2012). Effective suppression of breast tumor growth by an anti-EGFR/ErbB2 bispecific antibody. Cancer Letters.DOI
Qingqiao Tan, Qingcheng Guo, Chen Fang, Chong Wang, Bo-hua Li, Hao Wang, Jing Li, Yajun Guo (2012). Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products. mAbs.DOI
Wei Li, He Zhao, Wei-Zhu Qian, Hua-Fei Li, Li Zhang, Zengwei Ye, Ge Zhang, Mao Xia, Jinfeng Li, Jie Gao, Bo-hua Li, Geng Kou, Jianxin Dai, Hao Wang, Yajun Guo (2012). Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles. Biomaterials.DOI
Jie Gao, Yongsheng Yu, Yingying Zhang, Jinjing Song, Huaiwen Chen, Wei Li, Wei-Zhu Qian, Li Deng, Geng Kou, Jian-Ming Chen, Yajun Guo (2012). EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials.DOI
Wei Li, Qingchenig Guo, He Zhao, Li Zhang, Jinfeng Li, Jie Gao, Wei-Zhu Qian, Bo-hua Li, Huaiwen Chen, Hao Wang, Jianxin Dai, Yajun Guo (2012). Novel dual-control poly(N-isopropylacrylamide-co-chlorophyllin) nanogels for improving drug release. Nanomedicine.DOI
K. Fan, Bo Zhang, Hai'ou Yang, Hua-Jing Wang, Min Tan, S. Hou, Wei-Zhu Qian, Bo-hua Li, Hao Wang, Jianxin Dai, Yajun Guo (2011). A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in mice. European Journal of Pharmacology.DOI
Jian-Xin Dai, Hua-Jing Wang, Yajun Guo (2011). Function epitopes of staphylococcal enterotoxin B (SEB), monoclonal antibodies specifically bound with function epitopes and application of monoclonal antibodies.
Fang Zhao, Yi Zhang, Hao Wang, M. Jin, Shan He, Yu-Fang Shi, Yajun Guo, Yan-Yun Zhang (2011). Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease. Blood.DOI
Jianxin Dai, Lei Zhao, Hai'ou Yang, Huai-Zu Guo, K. Fan, Hua-Qing Wang, Wei-Zhu Qian, Da-peng Zhang, Bo-hua Li, Hao Wang, Yajun Guo (2011). Identification of a Novel Functional Domain of Ricin Responsible for Its Potent Toxicity*. Journal of Biological Chemistry.DOI
Yu Mi, Yutao Liu, Yajun Guo, Si-Shen Feng (2011). Herceptin®-conjugated nanocarriers for targeted imaging and treatment of HER2-positive cancer. Nanomedicine.DOI
Yong-Qiang Deng, Jian-Xin Dai, G. Ji, Tao Jiang, Hua-Jing Wang, Hai-ou Yang, Wen-Long Tan, Ran Liu, Man Yu, Bao-Xue Ge, Qing-yu Zhu, E. Qin, Yajun Guo, C. Qin (2011). A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein. PLoS ONE.DOI
Jie Gao, Wei Liu, Yunlei Xia, Wei Li, Jing Sun, Huaiwen Chen, Bo-hua Li, Da-peng Zhang, Wei-Zhu Qian, Yanchun Meng, Li Deng, Hao Wang, Jian-Ming Chen, Yajun Guo (2011). The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes. Biomaterials.DOI
Chong Wang, Xiaohui He, Bo Zhou, Jing Li, Bo-hua Li, Wei-Zhu Qian, S. Hou, Hao Wang, Yuan-Kai Shi, Yajun Guo (2011). Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors. mAbs.DOI
S. Chim, A. Qin, Jennifer C. Tickner, N. Pavlos, T. Davey, Hao Wang, Yajun Guo, M. Zheng, Jia-Ke Xu (2011). EGFL6 Promotes Endothelial Cell Migration and Angiogenesis through the Activation of Extracellular Signal-regulated Kinase*. Journal of Biological Chemistry.DOI
Wei Li, Jinfeng Li, Jie Gao, Bo-hua Li, Yunlei Xia, Yanchun Meng, Yongsheng Yu, Huaiwen Chen, Jianxin Dai, Hao Wang, Yajun Guo (2011). The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors. Biomaterials.DOI
Hai'ou Yang, Huai-Zu Guo, K. Fan, Bo Zhang, Lei Zhao, S. Hou, Wei-Zhu Qian, Da-peng Zhang, Hao Wang, Jianxin Dai, Yajun Guo (2011). Clearance of Propionibacterium acnes by kupffer cells is regulated by osteopontin through modulating the expression of p47phox. Molecular Immunology.DOI
Lan Wu, Chong Wang, Da-peng Zhang, Xunming Zhang, Wei-Zhu Qian, Lei Zhao, Hao Wang, Bo-hua Li, Yajun Guo (2010). Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma. Cancer Letters.DOI
Yong-Qiang Deng, G. Ji, Y. Kang, Tao Jiang, Jianxin Dai, E. Qin, Yajun Guo, C. Qin (2010). Characterization of a novel neutralizing monoclonal antibody that recognizes the fusion loop of Flavivirus envelope protein.DOI
Hui Yang, Jian-Chuang Wang, Jia-Mu Du, C. Zhong, Da-peng Zhang, Huai-Zu Guo, Yajun Guo, Jianping Ding (2010). Structural basis of immunosuppression by the therapeutic antibody daclizumab. Cell Research.DOI
Jian Zhao, Guo-Bin Wu, F. Bu, B. Lu, Anmin Liang, Lei Cao, Xin Tong, Xin Lu, Meng-chao Wu, Yajun Guo (2010). Epigenetic silence of ankyrin‐repeat–containing, SH3‐domain–containing, and proline‐rich‐region– containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus–positive hepatocellular carcinoma. Hepatology.DOI
Jie Gao, Si-Shen Feng, Yajun Guo (2010). Antibody engineering promotes nanomedicine for cancer treatment. Nanomedicine.DOI
Jianxin Dai, Bo-hua Li, Jinping Shi, Ling Peng, Da-peng Zhang, Wei-Zhu Qian, S. Hou, Lei Zhao, Jie Gao, Zhiguo Cao, Jian Zhao, Hao Wang, Yajun Guo (2010). Erratum to: A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo. Cancer Immunology and Immunotherapy.DOI
Cheng-Feng Qin, Qing-yu Zhu, Yong-Qiang Deng, Yajun Guo, Jian-Xin Dai, E. Qin, G. Ji, Tao Jiang (2010). Anti-flavivirus envelope E protein monoclonal antibody and application thereof.
B. Lu, Huai-Zu Guo, Jian Zhao, Chong Wang, Guo-Bin Wu, M. Pang, Xin Tong, F. Bu, Anmin Liang, S. Hou, Xiao-yu Fan, Jianxin Dai, Hao Wang, Yajun Guo (2010). Increased expression of iASPP, regulated by hepatitis B virus X protein-mediated NF-κB activation, in hepatocellular carcinoma. Gastroenterology.DOI
Yang Zhang, Hui-Mei Li, Jing Sun, Jie Gao, Wei Liu, Bo-hua Li, Yajun Guo, Jian-Ming Chen (2010). DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. International journal of pharmaceutics.DOI
M. Pang, Xia Chen, B. Lu, Jian Zhao, Bo-hua Li, Yu. Wei, Yajun Guo (2010). Lentiviral vector-mediated doxycycline-inducible iASPP gene targeted RNA interference in hepatocellular carcinoma. Chinese journal of cancer.
Yajun Guo, K. Fan, Jianxin Dai, Hao Wang, S. Hou, Jian Zhao (2010). Protective effects of anti-osteopontin monoclonal antibodies on osteoporosis.
Bo-hua Li, Xunming Zhang, Shu Shi, Lei Zhao, Da-peng Zhang, Wei-Zhu Qian, Lei Zheng, Jie Gao, Hao Wang, Yajun Guo (2010). Construction and characterization of a bispecific anti-CD20 antibody with potent antitumor activity against B-cell lymphoma. Cancer Research.DOI
Jianxin Dai, Bo-hua Li, Jinping Shi, Ling Peng, Da-peng Zhang, Wei-Zhu Qian, S. Hou, Lei Zhao, Jie Gao, Zhiguo Cao, Jian Zhao, Hao Wang, Yajun Guo (2010). A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo. Cancer Immunology and Immunotherapy.DOI
Jing Li, Bo Zhou, J. Shentu, Li Du, Min Tan, S. Hou, Wei-Zhu Qian, Bo-hua Li, Da-peng Zhang, Jianxin Dai, Hao Wang, Xu Zhang, Jiang-Hua Chen, Yajun Guo (2010). Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts. mAbs.DOI
Jie Gao, Jing Sun, Hui-Mei Li, Wei Liu, Yang Zhang, Bo-hua Li, Wei-Zhu Qian, Hao Wang, Jian-Ming Chen, Yajun Guo (2010). Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing. Biomaterials.DOI
Geng Kou, Jingping Shi, Lin Chen, Da-peng Zhang, S. Hou, Lei Zhao, Chen Fang, Lei Zheng, Xunming Zhang, P. Liang, Xu Zhang, Bo-hua Li, Yajun Guo (2010). A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin. Cancer Letters.DOI
Da-peng Zhang, Bo-hua Li, Jingping Shi, Lei Zhao, Xunming Zhang, Chong Wang, S. Hou, Wei-Zhu Qian, Geng Kou, Hao Wang, Yajun Guo (2010). Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein. Cancer Research.DOI
Xin Tong, Kai Li, Z. Luo, B. Lu, Xing Liu, Tao Wang, M. Pang, Bei-Bei Liang, M. Tan, Meng-chao Wu, Jian Zhao, Yajun Guo (2010). Tumorigenesis and Neoplastic Progression Decreased TIP30 Expression Promotes Tumor Metastasis in Lung Cancer.
Wei-Zhu Qian, Xunming Zhang, Bo-hua Li, Da-peng Zhang, Qing Tong, Lin Chen, Lei Zheng, Geng Kou, Hao Wang, S. Hou, Yajun Guo (2010). Development and characterization of a novel anti-IgE monoclonal antibody. Biochemical and Biophysical Research Communications - BBRC.DOI
Bo-hua Li, Lei Zhao, Chong Wang, Huai-Zu Guo, Lan Wu, Xunming Zhang, Wei-Zhu Qian, Hao Wang, Yajun Guo (2009). The Protein-Protein Interface Evolution Acts in a Similar Way to Antibody Affinity Maturation*. Journal of Biological Chemistry.DOI
Hao Wang, Huafeng Wei, Ruiping Zhang, S. Hou, Bo-hua Li, Wei-Zhu Qian, Da-peng Zhang, Geng Kou, Jianxin Dai, Yajun Guo (2009). Genetically Targeted T Cells Eradicate Established Breast Cancer in Syngeneic Mice. Clinical Cancer Research.DOI
An Yan, Guo-Hui Ding, Zhen Zhou, Hui Dong, Yakun Zhang, Lei Zhu, Yun-Xia He, Guoqing Zhang, Yi-Xue Li, Bing Sun, Zhong Huang, Ke Lan, Li Jin, Hong-Yan Wang, Xiaoning Wang, Zhong Yang, Yang Zhong, Jianxin Dai, Yajun Guo, Hao Wang, X. Che, Fan Wu, Zheng'an Yuan, Xi Zhang, Zhi-Wei Cao, Xiao-Nong Zhou, Jia-Hai Zhou, Zhi-Yong Ma, G. Tong, Guo-Ping Zhao, Weirong Jin, H. Xiong (2009). Subtyping of type A influenza by sequencing the variable regions of HA gene specifically amplified with RT-PCR.DOI
Yajun Guo, Bo-hua Li, Da-peng Zhang, Cai-Hui Li, Yan Zhang (2009). Anti-human CD20 humanized antibody and preparation method and application thereof.
Yajun Guo, Bo-hua Li, Hao Wang, S. Hou, Lei Zhao (2009). A high-affinity of CTLA4-Ig mutant fusion proteins.
Chang-Ming Cheng, Geng Kou, Xiaoling Wang, Shuhui Wang, H. Gu, Yajun Guo (2009). Synthesis of carboxyl superparamagnetic ultrasmall iron oxide (USPIO) nanoparticles by a novel flocculation-redispersion process.DOI
Yungang He, Guo-Hui Ding, C. Bian, Zhong Huang, Ke Lan, Bing Sun, Xue-Cai Wang, Yi-Xue Li, Hong-Yan Wang, Xiaoning Wang, Zhong Yang, Yang Zhong, Weirong Jin, H. Xiong, Jian-Xin Dai, Yajun Guo, Hao Wang, X. Che, Fan Wu, Zheng-an Yuan, Xi Zhang, Zhi-Wei Cao, Xiao-Nong Zhou, Jia-Hai Zhou, Zhi-Yong Ma, G. Tong, Guo-Ping Zhao, Li Jin(2009). 新甲型H1N1流感病毒血凝素基因(HA)突变网络结构.DOI
Jing Li, Xin-Yan Li, Min Tan, Bi-rong Lin, S. Hou, Wei-Zhu Qian, Bo-hua Li, Da-peng Zhang, Bo Zhou, Hao Wang, T. Zhu, Yajun Guo (2009). Two doses of humanized anti-CD25 antibody in renal transplantation. mAbs.DOI
Yajun Guo, Bo-hua Li, Hao Wang, S. Hou, Lei Zhao (2009). Procédé d'acquisition de protéines présentant une forte affinité au moyen d'une technique de conception assistée par ordinateur.
Jianxin Dai, Zhiguo Cao, Yanshen Kang, K. Fan, G. Ji, Hai'ou Yang, Hua-Jing Wang, Jie Gao, Hao Wang, Yajun Guo (2009). A functional motif QLYxxYP is essential for osteopontin induced T lymphocyte activation and migration. Biochemical and Biophysical Research Communications - BBRC.DOI
Jie Gao, Bo-hua Li, Hui-Mei Li, Xunming Zhang, Da-peng Zhang, Lei Zhao, Chong Wang, Chen Fang, Wei-Zhu Qian, S. Hou, Geng Kou, Huafeng Wei, Shu Shi, Hao Wang, Yajun Guo (2009). Development and characterization of a fully functional small anti-HER2 antibody. BMB Reports.DOI
Jia-Mu Du, Hui Yang, Da-peng Zhang, Jian-Chuang Wang, Huai-Zu Guo, Bao-Ying Peng, Yajun Guo, Jianping Ding (2009). BasiliximabSignaling by Therapeutic Antibody Structural Basis for the Blockage of IL-2.
Sheng Li, Hao Wang, B. Peng, Meilan Zhang, Dai-Zun Zhang, S. Hou, Yajun Guo, Jianping Ding (2009). Efalizumab binding to the LFA-1 αL I domain blocks ICAM-1 binding via steric hindrance. Proceedings of the National Academy of Sciences of the United States of America.DOI
Di Wu, Tianlei Xu, Jing Sun, Jianxin Dai, Guo-Hui Ding, Yun-Xia He, Zheng-Feng Zhou, H. Xiong, Hui Dong, Weirong Jin, C. Bian, Li Jin, Hong-Yan Wang, Xiaoning Wang, Zhong Yang, Yang Zhong, Hao Wang, X. Che, Zhong Huang, Ke Lan, Bing Sun, Fan Wu, ZhenAn Yuan, Xi Zhang, Xiao-Nong Zhou, Jia-Hai Zhou, Zhi-Yong Ma, G. Tong, Yajun Guo, Guo-Ping Zhao, Yi-Xue Li, Zhi-Wei Cao (2009). Structure modeling and spatial epitope analysis for HA protein of the novel H1N1 influenza virus.DOI
Jia-Mu Du, Hui Yang, Yajun Guo, Jianping Ding (2009). Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20. Molecular Immunology.DOI
Yajun Guo, Bo-hua Li, Hao Wang, S. Hou, Lei Zhao (2009). A high-affinity monoclonal antibodies against cd20.
Jie Gao, Geng Kou, Hao Wang, Huaiwen Chen, Bo-hua Li, Ying Lu, Da-peng Zhang, Shuhui Wang, S. Hou, Wei-Zhu Qian, Jianxin Dai, Jian Zhao, Yanqiang Zhong, Yajun Guo (2009). PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity. Breast Cancer Research and Treatment.DOI
Ling Peng, Yajun Guo, Yun Zhou, Jianxin Dai, Hao Wang (2009). Inhibition of Breast Cancer Metastasis and Angiogenesis by Antiosteopontin Single-Chain Fv-Fc Fusion Protein.DOI
Bo-hua Li, Lei Zhao, Huai-Zu Guo, Chong Wang, Xunming Zhang, Lan Wu, Lin Chen, Qing Tong, Wei-Zhu Qian, Hao Wang, Yajun Guo (2009). Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma. Blood.DOI
Wenxin Zheng, Run-Sheng Li, H. Pan, D. He, Rong Xu, Taylor B. Guo, Yajun Guo, Jing-Wu Z. Zhang (2009). Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis. Arthritis & Rheumatism.DOI